PDGFRB and Alzheimer disease: Bourassa et al., measured mural cell markers – PDGFRβ, CD13 and α‐SMA, in microvessels extracted from the parietal cortex of 60 participants in the Religious Orders study and found the marker levels to be reduced in AD in association with TDP‐43 levels [278].